Fulcrum Therapeutics, Massachusetts, United States
Caroline Sartain is a Senior Scientist in Fulcrum Therapeutics' Target Discovery group where she specializes in next-generation sequencing-based assays for drug discovery. Caroline holds a PhD in Genetics from Cornell University and completed her postdoctoral work at Washington State University. Caroline's academic work focused on genetic regulation of reproductive biology; in her industry work she pivoted toward NGS assay development. She has worked in Boston-area diagnostics and therapeutics companies since 2017, holding positions at Good Start Genetics and Torpedo Diagnostics before landing at Fulcrum Therapeutics, where she has led NGS lab efforts since 2019. Caroline was awarded Fulcrum Therapeutics' Innovation Award for her contributions toward the development of the FulcrumSeek™ screening platform.
Disclosure information not submitted.
Monday, February 7, 2022
5:00 PM – 5:30 PM